Kairos Pharma Ltd. (KAPA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.73
-0.04 (-2.26%)
At close: Jan 17, 2025, 3:59 PM
1.73
0.00%
After-hours Jan 17, 2025, 06:30 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -1.71M | -571.00K | -1.94M | -1.05M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -1.81M | -1.05M | -2.15M | -1.05M |
Net Income | -1.81M | -1.05M | -2.15M | -1.05M |
Selling & General & Admin | 1.47M | 324.00K | 1.66M | 1.03M |
Research & Development | 82.00K | 87.00K | 183.00K | 20.00K |
Other Expenses | 160.00K | 160.00K | 98.00K | n/a |
Operating Expenses | 1.71M | 571.00K | 1.94M | 1.05M |
Interest Expense | 98.00K | 479.00K | 202.00K | 5.41K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.71M | 571.00K | 1.94M | 1.05M |
Income Tax | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 10.38M | 10.24M | 12.84M | 11.22M |
Shares Outstanding (Diluted) | 10.38M | 10.24M | 12.84M | 11.22M |
EPS (Basic) | -0.17 | -0.1 | -0.17 | -0.09 |
EPS (Diluted) | -0.17 | -0.1 | -0.17 | -0.09 |
EBITDA | -1.55M | -431.00K | -1.88M | -1.05M |
Depreciation & Amortization | 160.00K | 160.00K | 98.00K | -58 |